Golestannejad Parsa, Monkaresi Mohamadparsa, Zhian Zargaran Farahnaz, Khosravani Mohammad, Asgari Pouya, Mobaraki Hesam, Gorjizad Mansour, Hasany Saina, Senobari Ghezeljehmeidan Aliakbar, Hemmati Sara, Zand Samaneh, Ghasemi Parsa, Asadi Anar Mahsa
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
BMC Cancer. 2025 Apr 1;25(1):582. doi: 10.1186/s12885-025-13965-9.
MicroRNAs (miRNAs) play a key role in regulating gene expression within the tumor microenvironment, influencing cancer progression and therapy response. Cancer-associated fibroblasts (CAFs) contribute to tumor development by secreting exosomal miRNAs that promote proliferation, invasion, and resistance. This systematic review evaluates the impact of CAF-derived miRNAs on head and neck malignancies.
A systematic search was conducted in PubMed, Scopus, WOS, and Google Scholar following PRISMA guidelines. Studies focusing on CAF-derived miRNAs in head and neck cancers were included. Data extraction covered study characteristics, miRNA profiling methods, functional roles, and clinical significance. The Scirap tool was used for quality assessment.
Among 921 identified articles, 21 met the inclusion criteria. Findings indicate that miR-21-5p, miR-106-5p, and miR-196a drive tumor progression in oral squamous cell carcinoma (OSCC), while miR-124 and miR-34a-5p act as suppressors. In esophageal squamous cell carcinoma (ESCC), miR-21 and miR-27a/b contribute to chemotherapy resistance, whereas miR-100-5p inhibits lymphangiogenesis. In head and neck squamous cell carcinoma (HNSCC), miR-196a and miR-196b may serve as diagnostic biomarkers. Exosomal miR-106a-5p promotes nasopharyngeal carcinoma (NPC) metastasis, and miR-7 and miR-196a contribute to therapy resistance in head and neck cancer (HNC).
CAF-derived miRNAs significantly influence tumor progression, metastasis, and therapy resistance. These findings highlight their potential as biomarkers and therapeutic targets, warranting further clinical research for personalized treatment strategies.
微小RNA(miRNA)在调节肿瘤微环境中的基因表达、影响癌症进展和治疗反应方面发挥着关键作用。癌症相关成纤维细胞(CAF)通过分泌促进增殖、侵袭和耐药的外泌体miRNA,促进肿瘤发展。本系统评价评估了CAF衍生的miRNA对头颈部恶性肿瘤的影响。
按照PRISMA指南在PubMed、Scopus、WOS和谷歌学术中进行系统检索。纳入关注头颈部癌症中CAF衍生的miRNA的研究。数据提取涵盖研究特征、miRNA分析方法、功能作用和临床意义。使用Scirap工具进行质量评估。
在921篇已识别的文章中,21篇符合纳入标准。研究结果表明,miR-21-5p、miR-106-5p和miR-196a促进口腔鳞状细胞癌(OSCC)的肿瘤进展,而miR-124和miR-34a-5p起抑制作用。在食管鳞状细胞癌(ESCC)中,miR-21和miR-27a/b导致化疗耐药,而miR-100-5p抑制淋巴管生成。在头颈部鳞状细胞癌(HNSCC)中,miR-196a和miR-196b可用作诊断生物标志物。外泌体miR-106a-5p促进鼻咽癌(NPC)转移,miR-7和miR-196a导致头颈癌(HNC)治疗耐药。
CAF衍生的miRNA显著影响肿瘤进展、转移和治疗耐药。这些发现凸显了它们作为生物标志物和治疗靶点的潜力,有必要进一步开展临床研究以制定个性化治疗策略。